Latest period
4.45B
YoY change
-0.3%
5Y CAGR
-1.0%
Peak year (1989)
8.06B
Latest annual
4.45B
Shares Outstanding history chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: 4.45B
Shares Outstanding growth chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: -0.3%
Shares Outstanding history table for Novo Nordisk (NVO) from 1985 to 2025
| 2025 | 4.45B | -0.3% | -15.15M | ||
| 2024 | 4.46B | -0.7% | -31.80M | ||
| 2023 | 4.49B | -1.1% | -49.80M | ||
| 2022 | 4.54B | -1.3% | -61.60M | ||
| 2021 | 4.61B | -1.6% | -73.80M | ||
| 2020 | 4.68B | -1.6% | -77.32M | ||
| 2019 | 4.76B | -1.9% | -91.52M | ||
| 2018 | 4.85B | -2.2% | -107.35M | ||
| 2017 | 4.96B | -2.2% | -114.00M | ||
| 2016 | 5.07B | -1.7% | -86.62M | ||
| 2015 | 5.16B | -2.0% | -103.63M | ||
| 2014 | 5.26B | -2.4% | -126.81M | ||
| 2013 | 5.39B | -2.3% | -129.43M | ||
| 2012 | 5.52B | -3.2% | -184.64M | ||
| 2011 | 5.70B | -2.6% | -153.56M | ||
| 2010 | 5.85B | -3.1% | -187.77M | ||
| 2009 | 6.04B | -3.0% | -183.77M | ||
| 2008 | 6.23B | -2.1% | -130.55M | ||
| 2007 | 6.36B | -1.6% | -102.10M | ||
| 2006 | 6.46B | -2.0% | -130.37M | ||
| 2005 | 6.59B | -3.0% | -200.51M | ||
| 2004 | 6.79B | -1.3% | -90.10M | ||
| 2003 | 6.88B | -1.5% | -101.72M | ||
| 2002 | 6.98B | +0.7% | +45.67M | ||
| 2001 | 6.94B | -0.1% | -4.32M | ||
| 2000 | 6.94B | -1.1% | -79.59M | ||
| 1999 | 7.02B | -4.5% | -330.00M | ||
| 1998 | 7.35B | -2.5% | -187.21M | ||
| 1997 | 7.54B | +0.9% | +65.60M | ||
| 1996 | 7.47B | -0.6% | -43.06M | ||
| 1995 | 7.51B | +0.6% | +41.65M | ||
| 1994 | 7.47B | -0.6% | -44.84M | ||
| 1993 | 7.52B | +0.0% | +3.04M | ||
| 1992 | 7.51B | +29.0% | +1.69B | ||
| 1991 | 5.83B | -7.0% | -440.74M | ||
| 1990 | 6.27B | -22.3% | -1.80B | ||
| 1989 | 8.06B | +56.4% | +2.91B | ||
| 1988 | 5.16B | +1.4% | +71.68M | ||
| 1987 | 5.08B | +0.2% | +12.44M | ||
| 1986 | 5.07B | +1.0% | +49.21M | ||
| 1985 | 5.02B | — | — |
- 20254.45B-0.3%
- 20244.46B-0.7%
- 20234.49B-1.1%
- 20224.54B-1.3%
- 20214.61B-1.6%
- 20204.68B-1.6%
- 20194.76B-1.9%
- 20184.85B-2.2%
- 20174.96B-2.2%
- 20165.07B-1.7%
- 20155.16B-2.0%
- 20145.26B-2.4%
- 20135.39B-2.3%
- 20125.52B-3.2%
- 20115.70B-2.6%
- 20105.85B-3.1%
- 20096.04B-3.0%
- 20086.23B-2.1%
- 20076.36B-1.6%
- 20066.46B-2.0%
- 20056.59B-3.0%
- 20046.79B-1.3%
- 20036.88B-1.5%
- 20026.98B+0.7%
- 20016.94B-0.1%
- 20006.94B-1.1%
- 19997.02B-4.5%
- 19987.35B-2.5%
- 19977.54B+0.9%
- 19967.47B-0.6%
- 19957.51B+0.6%
- 19947.47B-0.6%
- 19937.52B+0.0%
- 19927.51B+29.0%
- 19915.83B-7.0%
- 19906.27B-22.3%
- 19898.06B+56.4%
- 19885.16B+1.4%
- 19875.08B+0.2%
- 19865.07B+1.0%
- 19855.02B—
Shares Outstanding values are taken from Novo Nordisk's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
About Shares Outstanding at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported diluted shares outstanding is 4.45B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Novo Nordisk (NVO) diluted shares outstanding is 4.45B – edged down 0.3% year-over-year.
Over 2020–2025 (5 years), Novo Nordisk diluted shares outstanding expanded at a -1.0% compound annual rate, with a net decline across the window.
Novo Nordisk diluted shares outstanding peaked at 8.06B in 1989; the latest annual figure is 4.45B in 2025 (44.8% below peak).
1989 marks the peak diluted shares outstanding at 8.06B, with the historical low of 4.45B recorded in 2025.
Novo Nordisk Shares Outstanding by Year
Novo Nordisk Shares Outstanding 2025: 4.45B
Novo Nordisk posted diluted shares outstanding of 4.45B in 2025, edged down 0.3% below 2024. This figure represents the lowest annual value in the available history.
Novo Nordisk Shares Outstanding 2024: 4.46B
In 2024, Novo Nordisk reported diluted shares outstanding of 4.46B, edged down 0.7% below 2023.
Novo Nordisk Shares Outstanding 2023: 4.49B
Novo Nordisk diluted shares outstanding in 2023 was 4.49B, edged down 1.1% below 2022.
Novo Nordisk Shares Outstanding 2022: 4.54B
2022's diluted shares outstanding for Novo Nordisk came in at 4.54B, edged down 1.3% below 2021.
Novo Nordisk Shares Outstanding 2021: 4.61B
Novo Nordisk diluted shares outstanding in 2021 was 4.61B.
See more financial history for Novo Nordisk (NVO).
Sector peers by Shares Outstanding
Healthcare peers of Novo Nordisk (NVO), ranked by their latest diluted shares outstanding
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M | |
| 377.00M |
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation